Loading...
Bilateral Trade Intelligence · $128.4K Total Trade · 12 Foreign Suppliers · 15 Indian Buyers · DGFT Verified · Updated March 2026
India imported $128.4K worth of pharmaceutical formulations from Latvia across 64 verified shipments, from 12 foreign suppliers to 15 Indian buyers. The top suppliers are RECIPE PLUS JSC ($44.7K) and SIA GP NORD ($29.6K). The leading products are Bisoprolol ($27K) and Semaglutide ($25K). Average shipment value: $2.0K.
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Bisoprolol | $26.9K | 20.9% |
| 2 | Semaglutide | $24.9K | 19.4% |
| 3 | Amphotericin | $12.7K | 9.9% |
| 4 | Iron | $6.3K | 4.9% |
| 5 | Vitamin | $6.3K | 4.9% |
| 6 | Trastuzumab | $5.8K | 4.5% |
| 7 | Tobramycin | $5.7K | 4.5% |
| 8 | Vancomycin | $4.4K | 3.4% |
| 9 | Enoxaparin | $4.2K | 3.3% |
| 10 | Sodium | $4.2K | 3.3% |
| 11 | Gabapentin | $3.6K | 2.8% |
| 12 | Gentamicin | $2.4K | 1.9% |
| 13 | Dexamethasone | $2.1K | 1.7% |
| 14 | Moxifloxacin | $2.0K | 1.5% |
| 15 | Rivaroxaban | $1.9K | 1.5% |
India imports 20+ pharmaceutical formulations from Latvia with a combined trade value of $128.4K. Key products include Bisoprolol ($27K), Semaglutide ($25K), Amphotericin ($13K), Iron ($6K), Vitamin ($6K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 64 verified Indian Customs (DGFT) shipment records.
India exported pharmaceuticals worth $128.4K to Latvia across 64 verified shipments.
1. RECIPE PLUS JSC — $44.7K. 2. SIA GP NORD — $29.6K. 3. RX SOLUTION LIMITED — $20.8K. Total: 12 suppliers.
1. ACULIFE HEALTHCARE PRIVATE LIMITED — $35.7K. 2. RUSAN PHARMA LIMITED — $26.9K. 3. INTAS PHARMACEUTICALS LIMITED — $26.6K. 15 buyers total.
1. Bisoprolol ($26.9K, 20.9%); 2. Semaglutide ($24.9K, 19.4%); 3. Amphotericin ($12.7K, 9.9%); 4. Iron ($6.3K, 4.9%); 5. Vitamin ($6.3K, 4.9%)
Export: . Import: .
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $128.4K corridor reflects quality compliance and pricing advantages.
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
These are the top pharmaceutical products exported from India to Latvia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Latvia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Bisoprolol ($27K), Semaglutide ($25K), Amphotericin ($13K), Iron ($6K), Vitamin ($6K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
12 Indian pharmaceutical companies export finished formulations to Latvia. Leading exporters include Recipe Plus Jsc, Sia Gp Nord, Rx Solution Limited, E-pharm Limited. The top exporter accounts for 34.8% of total India–Latvia pharma exports. Source: Indian Customs (DGFT).
15 companies in Latvia import pharmaceutical formulations from India. Top buyers include Aculife Healthcare Private Limited, Rusan Pharma Limited, Intas Pharmaceuticals Limited, Hetero Labs Limited. The largest buyer accounts for 27.8% of India–Latvia pharma imports. Source: Indian Customs (DGFT).
$2.0K per consignment across 64 shipments.
12 Indian companies. Largest: RECIPE PLUS JSC with $44.7K.
TransData Nexus covers 12 active exporters with shipment history and trade values at transdatanexus.com.
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 64 shipments.
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Exporters
15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists